Lista de obras - Volker Erfle - Dominio Público Uruguay

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

artículo científico publicado en 2011

A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus

scientific article published on 01 December 2008

Autologous cytotoxicity of natural killer cells derived from HIV-infected patients

artículo científico publicado en 2004

Differences between T cell epitopes recognized after immunization and after infection

artículo científico publicado en 2002

Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletes.

artículo científico publicado en 2010

Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08

artículo científico publicado en 2002

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

artículo científico publicado en 2007

Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8⁺ T Cell Epitopes

artículo científico publicado en 2014

Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy

artículo científico publicado en 2002

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

artículo científico publicado en 2002

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.

artículo científico publicado en 2007

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

article

Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.

artículo científico publicado en 2002

Improved host range selection for recombinant modified vaccinia virus Ankara

artículo científico publicado en 2003

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara

artículo científico publicado en 2005

Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity

artículo científico publicado en 2006

Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic

article

Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection

artículo científico publicado en 2008

Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model

artículo científico publicado en 2010

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.

artículo científico publicado en 2003

Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection.

artículo científico publicado en 2010

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

artículo científico publicado en 2004

Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model

artículo científico publicado en 2007

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

artículo científico publicado en 2003

The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.

artículo científico publicado en 2009

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

artículo científico publicado en 2008

Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy

artículo científico publicado en 2007

Therapeutic vaccination reduces HIV sequence variability

article

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

article

Unsung Hero Robert C. Gallo

artículo científico publicado en 2009

Vaccines based on Nef and on Nef/DeltaV2 Env

artículo científico publicado en 2005

Lista de obras de Volker Erfle

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus

Autologous cytotoxicity of natural killer cells derived from HIV-infected patients

Differences between T cell epitopes recognized after immunization and after infection

Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletes.

Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8⁺ T Cell Epitopes

Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.

Improved host range selection for recombinant modified vaccinia virus Ankara

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara

Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity

Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic

Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection

Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.

Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection.

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy

Therapeutic vaccination reduces HIV sequence variability

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

Unsung Hero Robert C. Gallo

Vaccines based on Nef and on Nef/DeltaV2 Env